INS and type 2 diabetes mellitus: (2012) reported that postmenopausal women with T2DM who took flavan-3-ols and isoflavones for a year exhibited significant reductions in estimated peripheral insulin resistance and persistent improvements in lipid profile and insulin sensitivity (155).